• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有适应性治疗选择的灵活序贯组设计中的检验与估计

Testing and estimation in flexible group sequential designs with adaptive treatment selection.

作者信息

Posch Martin, Koenig Franz, Branson Michael, Brannath Werner, Dunger-Baldauf Cornelia, Bauer Peter

机构信息

Section of Medical Statistics, Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Spitalgasse 23, A-1090 Wien, Austria.

出版信息

Stat Med. 2005 Dec 30;24(24):3697-714. doi: 10.1002/sim.2389.

DOI:10.1002/sim.2389
PMID:16320264
Abstract

Integrating selection and confirmation phases into a single trial can expedite the development of new treatments and allows to use all accumulated data in the decision process. In this paper we review adaptive treatment selection based on combination tests and propose overall adjusted p-values and simultaneous confidence intervals. Also point estimation in adaptive trials is considered. The methodology is illustrated in a detailed example based on an actual planned study.

摘要

将选择阶段和确认阶段整合到一个单一试验中,可以加快新治疗方法的开发,并允许在决策过程中使用所有积累的数据。在本文中,我们回顾了基于联合检验的适应性治疗选择,并提出了总体调整后的p值和同时置信区间。此外,还考虑了适应性试验中的点估计。通过一个基于实际计划研究的详细例子来说明该方法。

相似文献

1
Testing and estimation in flexible group sequential designs with adaptive treatment selection.具有适应性治疗选择的灵活序贯组设计中的检验与估计
Stat Med. 2005 Dec 30;24(24):3697-714. doi: 10.1002/sim.2389.
2
Adaptive designs for confirmatory clinical trials.确证性临床试验的适应性设计
Stat Med. 2009 Apr 15;28(8):1181-217. doi: 10.1002/sim.3538.
3
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.序贯样本量重新估计试验后参数估计及其精确置信区间
Biometrics. 2004 Dec;60(4):910-8. doi: 10.1111/j.0006-341X.2004.00246.x.
4
Flexible design of two-stage adaptive procedures for phase III clinical trials.III期临床试验两阶段适应性程序的灵活设计
Contemp Clin Trials. 2007 Jul;28(4):500-13. doi: 10.1016/j.cct.2007.01.007. Epub 2007 Jan 23.
5
A comparison of adaptive allocation rules for group-sequential binary response clinical trials.成组序贯二元反应临床试验的适应性分配规则比较
Stat Med. 2007 Apr 30;26(9):1937-54. doi: 10.1002/sim.2693.
6
Repeated confidence intervals for adaptive group sequential trials.适应性成组序贯试验的重复置信区间
Stat Med. 2007 Dec 30;26(30):5422-33. doi: 10.1002/sim.3062.
7
Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.评估在区间内存在治疗差异时灵活样本量设计的适应性表现。
Stat Med. 2008 Feb 20;27(4):584-96. doi: 10.1002/sim.2998.
8
Estimation in flexible two stage designs.灵活两阶段设计中的估计
Stat Med. 2006 Oct 15;25(19):3366-81. doi: 10.1002/sim.2258.
9
Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.适应性成组序贯试验设计中比例研究的数据驱动分析策略。
J Biopharm Stat. 2003 Nov;13(4):585-603. doi: 10.1081/BIP-120024196.
10
A comparison of methods for adaptive treatment selection.自适应治疗选择方法的比较。
Biom J. 2008 Oct;50(5):767-81. doi: 10.1002/bimj.200710453.

引用本文的文献

1
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization.在具有剂量优化的适应性2/3期设计中对不一致性的调整。
Pharm Stat. 2025 Nov-Dec;24(6):e70031. doi: 10.1002/pst.70031.
2
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
3
A Seamless Hybrid Phase II/III Design With Bayesian Interim Subgroup Selection.一种采用贝叶斯中期亚组选择的无缝混合II/III期设计。
Stat Med. 2025 Jun;44(13-14):e70144. doi: 10.1002/sim.70144.
4
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma.SaLudo:一项关于鲁比卡丁联合多柔比星作为平滑肌肉瘤一线治疗的随机IIb/III期研究。
Future Oncol. 2025 Apr;21(8):943-951. doi: 10.1080/14796694.2025.2463798. Epub 2025 Feb 11.
5
The impact of heterogeneity on the analysis of platform trials with normally distributed outcomes.平台试验中异质性对正态分布结局分析的影响。
BMC Med Res Methodol. 2024 Jul 30;24(1):163. doi: 10.1186/s12874-024-02293-4.
6
Seamless phase II/III design: a useful strategy to reduce the sample size for dose optimization.无缝二期/三期设计:一种用于减少剂量优化样本量的有用策略。
J Natl Cancer Inst. 2023 Sep 7;115(9):1092-1098. doi: 10.1093/jnci/djad103.
7
Adjusting for treatment selection in phase II/III clinical trials with time to event data.调整具有生存时间数据的 II/III 期临床试验中的治疗选择。
Stat Med. 2023 Jan 30;42(2):146-163. doi: 10.1002/sim.9606. Epub 2022 Nov 23.
8
The benefits of covariate adjustment for adaptive multi-arm designs.协变量调整对自适应多臂设计的好处。
Stat Methods Med Res. 2022 Nov;31(11):2104-2121. doi: 10.1177/09622802221114544. Epub 2022 Jul 25.
9
Estimands and Complex Innovative Designs.估算目标和复杂创新设计。
Clin Pharmacol Ther. 2022 Dec;112(6):1183-1190. doi: 10.1002/cpt.2575. Epub 2022 Mar 29.
10
Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs.两阶段自适应富集和伞式设计中的亚组选择优化。
Stat Med. 2021 May 30;40(12):2939-2956. doi: 10.1002/sim.8949. Epub 2021 Mar 29.